SJM earnings analysis: questions answered and next catalysts

J.M. Smucker (SJM) delivered a strong Q1 2027, beating EPS expectations by 46.6% with $3.24 per share, compared to the $2.21 consensus. This beat was driven by a $115 million tariff refund windfall. The company's stock surged to a 52-week high of $134.85, and management raised full-year EPS guidance to $10.50–$11.00, surpassing the $10.05 estimate from analysts.

Tariffs were the central question heading into the quarter, but management clarified that the $0.84 per share refund in Q1 was a one-time reconciliation and not a recurring benefit. For the full year, the net benefit is expected to be around $0.60 per share after accounting for reinvestment and costs.

The U.S. Retail Coffee segment stood out, with sales growing 13% to $807.8 million and segment profit up 124% year-over-year. Margins expanded by an impressive 1,840 basis points to 37.1%. This success suggests that SJM can handle green coffee cost volatility without negatively impacting volume.

Uncrustables showed 12% net sales growth with double-digit volume gains, leading management to raise its full-year growth outlook to high single digits, up from a mid-single-digit range. Café Bustelo also delivered strong results, growing 23% and contributing 8% to volume, highlighting the company's diverse portfolio.

However, Sweet Baked Snacks experienced a 7% drop in sales with profit down 13%, likely due to weaker traffic and lower volume. The Hostess brand portfolio is undergoing simplification through a 25% SKU reduction, but this segment remains a drag. The company met its 3x leverage target in Q1, and net debt/EBITDA improved to 2.9x from 3.8x, with $230 million paid down in the quarter alone.

Free cash flow turned positive, reaching $337.3 million, up from a negative $94.9 million the previous year. This improvement opens the door to potential share repurchases, a capital return tool SJM has not utilized recently.

Following the beat, UBS raised its price target to $142 with a Buy rating, while JPMorgan set it at $139 with an Overweight rating. Morgan Stanley, however, downgraded to an Equal-weight rating with a $105 target, suggesting that the positive trends are already priced in.

The Street is currently divided, with six positive EPS revisions and four negative ones over the past 90 days. Analysts appear cautiously optimistic about SJM's future, but a decisive catalyst is needed to determine whether this quarter's success marks the beginning of a sustainable re-rating or just a temporary windfall.